Improved Transduction of Human Sheep Repopulating Cells by Retrovirus Vectors Pseudotyped with Feline Leukemia Virus Type C or RD114 Envelopes

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2005 Mar 19

PMID 15774617

Citations 9

Authors

M Lee Lucas

Nancy E Seidel

Christopher D Porada

John G Quigley

Stacie M Anderson

Harry L Malech

Janis L Abkowitz

Esmail D Zanjani

David M Bodine

Affiliations

Soon will be listed here.

Abstract

Gene therapy for hematopoietic diseases has been hampered by the low frequency of transduction of human hematopoietic stem cells (HSCs) with retroviral vectors pseudotyped with amphotropic envelopes. We hypothesized that transduction could be increased by the use of retroviral vectors pseudotyped with envelopes that recognize more abundant cellular receptors. The levels of mRNA encoding the receptors of the feline retroviruses, RD114 and feline leukemia virus type C (FeLV-C), were significantly higher than the level of gibbon ape leukemia virus (GaLV) receptor mRNA in cells enriched for human HSCs (Lin- CD34+ CD38-). We cotransduced human peripheral blood CD34+ cells with equivalent numbers of FeLV-C and GALV or RD114 and GALV-pseudotyped retroviruses for injection into fetal sheep. Analysis of DNA from peripheral blood and bone marrow from recipient sheep demonstrated that FeLV-C- or RD114-pseudotyped vectors were present at significantly higher levels than GALV-pseudotyped vectors. Analysis of individual myeloid colonies demonstrated that retrovirus vectors with FeLV-C and RD114 pseudotypes were present at 1.5 to 1.6 copies per cell and were preferentially integrated near known genes We conclude that the more efficient transduction of human HSCs with either FeLV-C- or RD114-pseudotyped retroviral particles may improve gene transfer in human clinical trials.

Citing Articles

FLVCR is necessary for erythroid maturation, may contribute to platelet maturation, but is dispensable for normal hematopoietic stem cell function.

Byon J, Chen J, Doty R, Abkowitz J Blood. 2013; 122(16):2903-10.

PMID: 24021674 PMC: 3799002. DOI: 10.1182/blood-2012-10-465104.

Heme and FLVCR-related transporter families SLC48 and SLC49.

Khan A, Quigley J Mol Aspects Med. 2013; 34(2-3):669-82.

PMID: 23506900 PMC: 3602793. DOI: 10.1016/j.mam.2012.07.013.

Control of intracellular heme levels: heme transporters and heme oxygenases.

Khan A, Quigley J Biochim Biophys Acta. 2011; 1813(5):668-82.

PMID: 21238504 PMC: 3079059. DOI: 10.1016/j.bbamcr.2011.01.008.

A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.

Oliveira N, Trikha R, McKnight A Retrovirology. 2010; 7:81.

PMID: 20929586 PMC: 2959036. DOI: 10.1186/1742-4690-7-81.

Large animal models of hematopoietic stem cell gene therapy.

Trobridge G, Kiem H Gene Ther. 2010; 17(8):939-48.

PMID: 20428209 PMC: 2914814. DOI: 10.1038/gt.2010.47.

References

Crooks G, Kohn D . Growth factors increase amphotropic retrovirus binding to human CD34+ bone marrow progenitor cells. Blood. 1993; 82(11):3290-7. View

Miller D, EDWARDS R, Miller A . Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci U S A. 1994; 91(1):78-82. PMC: 42889. DOI: 10.1073/pnas.91.1.78. View

van Zeijl M, Johann S, Closs E, Cunningham J, Eddy R, Shows T . A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc Natl Acad Sci U S A. 1994; 91(3):1168-72. PMC: 521475. DOI: 10.1073/pnas.91.3.1168. View

Kavanaugh M, Miller D, Zhang W, Law W, Kozak S, Kabat D . Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A. 1994; 91(15):7071-5. PMC: 44340. DOI: 10.1073/pnas.91.15.7071. View

Kozak S, Siess D, Kavanaugh M, Miller A, Kabat D . The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J Virol. 1995; 69(6):3433-40. PMC: 189055. DOI: 10.1128/JVI.69.6.3433-3440.1995. View

Dunbar C, Cottler-Fox M, OShaughnessy J, Doren S, Carter C, Berenson R . Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 1995; 85(11):3048-57. View

Kohn D, Bauer G, Rice C, Rothschild J, Carbonaro D, Valdez P . A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood. 1999; 94(1):368-71. View

Cowan K, Moscow J, Huang H, Zujewski J, OShaughnessy J, SORRENTINO B . Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin Cancer Res. 1999; 5(7):1619-28. View

Murray L, Luens K, Tushinski R, Jin L, Burton M, Chen J . Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture. Hum Gene Ther. 1999; 10(11):1743-52. DOI: 10.1089/10430349950017428. View

10.

Sawai N, Persons D, Zhou S, Lu T, Sorrentino B . Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expression. Mol Ther. 2003; 8(3):376-84. DOI: 10.1016/s1525-0016(03)00205-3. View

11.

Baum C, Dullmann J, Li Z, Fehse B, Meyer J, Williams D . Side effects of retroviral gene transfer into hematopoietic stem cells. Blood. 2003; 101(6):2099-114. DOI: 10.1182/blood-2002-07-2314. View

12.

Kelly P, Donahue R, Vandergriff J, Takatoku M, Bonifacino A, Agricola B . Prolonged multilineage clonal hematopoiesis in a rhesus recipient of CD34 positive cells marked with a RD114 pseudotyped oncoretroviral vector. Blood Cells Mol Dis. 2003; 30(1):132-43. DOI: 10.1016/s1079-9796(03)00005-6. View

13.

Quigley J, Burns C, Anderson M, Lynch E, Sabo K, Overbaugh J . Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood. 2000; 95(3):1093-9. View

14.

Cavazzana-Calvo M, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F . Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000; 288(5466):669-72. DOI: 10.1126/science.288.5466.669. View

15.

Abonour R, Williams D, Einhorn L, Hall K, Chen J, Coffman J . Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med. 2000; 6(6):652-8. DOI: 10.1038/76225. View

16.

Sauvageau G, Thorsteinsdottir U, Eaves C, Lawrence H, Largman C, Lansdorp P . Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 1995; 9(14):1753-65. DOI: 10.1101/gad.9.14.1753. View

17.

Kohn D, Weinberg K, Nolta J, Heiss L, Lenarsky C, Crooks G . Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med. 1995; 1(10):1017-23. PMC: 3013367. DOI: 10.1038/nm1095-1017. View

18.

Cosset F, Takeuchi Y, Battini J, Weiss R, Collins M . High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol. 1995; 69(12):7430-6. PMC: 189680. DOI: 10.1128/JVI.69.12.7430-7436.1995. View

19.

Malhotra S, Scott A, Zavorotinskaya T, Albritton L . Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry. J Virol. 1996; 70(1):321-6. PMC: 189820. DOI: 10.1128/JVI.70.1.321-326.1996. View

20.

Battini J, Rodrigues P, Muller R, Danos O, Heard J . Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J Virol. 1996; 70(7):4387-93. PMC: 190372. DOI: 10.1128/JVI.70.7.4387-4393.1996. View